XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net (loss) income $ (41,169) $ 30,983
Less: (Loss) income from discontinued operations (62,902) 540
Income from continuing operations 21,733 30,443
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Depreciation and amortization 28,465 32,940
Non-cash lease expense, net (5,186) (5,649)
Stock-based compensation expense 15,348 4,822
Deferred taxes (467) 5,772
Impairment of assets and long-term investments 0 172
Equity in net loss of unconsolidated investments 605 64
Other (income) loss, net (1,354) 43
Changes in operating assets and liabilities (net of businesses acquired):    
Accounts receivable and contract assets, net 28,751 11,814
Prepaid expenses and other assets 10,248 (4,513)
Accounts payable 25,246 1,422
Accrued expenses 12,440 37,725
Accrued compensation and benefits (3,215) (10,421)
Deferred revenue (35,156) (20,526)
Other liabilities (20,798) 4,145
Net cash provided by operating activities - continuing operations 76,660 88,253
Net cash provided by (used in) operating activities - discontinued operations (9,034) (284,615)
Net cash provided by (used in) operating activities 67,626 (196,362)
Cash flows from investing activities:    
Capital expenditures (1,652) (225)
Capitalized software (18,258) (16,735)
Cash paid for business acquisitions, net of cash acquired (24,106) 0
Sale of businesses and other investments, net of cash divested, and distributions received 672,488 4,242
Purchases of equity securities, other investments and related intangible assets, net (251) (221)
Net cash provided by (used in) investing activities - continuing operations 628,221 (12,939)
Net cash used in investing activities - discontinued operations (15,248) (21,606)
Net cash provided by (used in) investing activities 612,973 (34,545)
Cash flows from financing activities:    
Taxes paid related to net share settlement of equity awards (27,871) (12,638)
Credit facility payments (200,000) 0
Credit facility borrowings, net of issuance costs 22,335 250,000
Repurchase of common stock (143,372) (308,953)
Intercompany to/from parent/subsidiaries 11,685 4,987
Payment of acquisition and other financing obligations 0 (2,400)
Net cash used in financing activities - continuing operations (337,223) (69,004)
Net cash used in financing activities - discontinued operations (11,697) (6,236)
Net cash used in financing activities (348,920) (75,240)
Effect of exchange rate changes on cash and cash equivalents (728) 65
Net increase (decrease) in cash and cash equivalents 330,951 (306,082)
Cash, cash equivalents and restricted cash, beginning of period 190,520 537,465
Cash, cash equivalents and restricted cash, end of period 521,471 231,383
Less: Cash and cash equivalents attributable to discontinued operations (20,000) (70,520)
Cash, cash equivalents and restricted cash, end of period, excluding discontinued operations $ 501,471 $ 160,863